Paper Title

Development and optimization of orodispersible films for the treatment of mouth ulcer

Article Identifiers

Registration ID: IJNRD_186647

Published ID: IJNRD2303014

DOI: Click Here to Get

Authors

Manjunatha , Beny Baby , S. Rajarajan , Rashmi mathews , K Ramesh

Keywords

Abstract

Orodispersible dosage forms are new methods for drug delivery system. Orodispersible dosage forms are the most advanced form of oral solid dosage form Because of their more flexibility and convenience. It enhances the efficacy of APIs by dissolving in the oral cavity within a minute without the need for water. The aim of the study was to develop an orodispersible film (ODF) as an alternative dosage forms as compared to tablets, syrups, or suppositories. This is mainly focused on the treatment of mouth ulcers, especially for the peadiatric and geriatric patients. The Solvent Casting method was used to prepare orodispersible films of dexlansoprazole by incorporating polymers such as HPMC, Lycoat RS780, Croscarmelallose as disintegrates, and PEG 400 as plasticizers. The orodispersible films of dexlansoprazole were evaluated to weight variation, Drug content, surface pH, Disintegration time, Swelling Index, Folding Endurance, Film Thickness and In-vitro drug release. The drug release tests were carried out for 8 hours at 37°C1°C in phosphate buffer (pH 6.8). The optimised formulation was carried out with the help of a design expert in the Quadratic model 13.0.5.0 version. The optimised formulation of orodispersible films was subjected to an accelerated stability study and found to be stable at 40°C/75% RH for 3 month according to ICH guidelines. The results, results of the orodispersible films of dexlansoprazole, evaluation of all physicochemical parameters will reveal good results. The orodispersible films of dexlansoprazole for the drug release study at 8h, % cumulative drug release of 83.90 to 96.80%. The optimised formulation for design was found to be DL15, which showed 86.90% drug release at 8h and DL15 was found to be stable when stored at 40ºC/75% RH for 3 month according to ICH guidelines with no significant changes on further stability study.

How To Cite (APA)

Manjunatha, Beny Baby, S. Rajarajan , Rashmi mathews, & K Ramesh (March-2023). Development and optimization of orodispersible films for the treatment of mouth ulcer. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 8(3), a143-a156. https://ijnrd.org/papers/IJNRD2303014.pdf

Issue

Volume 8 Issue 3, March-2023

Pages : a143-a156

Other Publication Details

Paper Reg. ID: IJNRD_186647

Published Paper Id: IJNRD2303014

Downloads: 000121992

Research Area: Pharmacy

Country: Bangalore , Karnataka, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2303014.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2303014

About Publisher

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

Publication Timeline

Peer Review
Through Scholar9.com Platform

Article Preview: View Full Paper

Call For Paper

Call For Paper - Volume 10 | Issue 10 | October 2025

IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.

Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.

How to submit the paper?

Important Dates for Current issue

Paper Submission Open For: October 2025

Current Issue: Volume 10 | Issue 10 | October 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Oct-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details